PreMD Provides Update on FDA Review(atent applications may be challenged inv...),Health
Navigation Links
PreMD Provides Update on FDA Review
Date:4/11/2008
atent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates.
Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. PreMD is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
(x) Trademark
'/>"/>
| SOURCE PreMD Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. PreMD Reports Fiscal 2007 Results
2. PreMD Inc. Completes Debenture Financing
3. PreMD Inc. Signs Agreement with Cosmetics Conglomerate
4. PreMD Inc. Announces Debenture Financing
5. PreMD Initiates FDA Review Process and Provides Corporate Update
6. PreMD Announces FDA Decision on POC Skin Cholesterol Test
7. PreMD Announces Valuable Data on PREVU(x) LT Life Insurance Product
8. PreMD Inc. Provides Corporate Update
9. PreMD Provides Update on 510(k) Application for PREVU(x) POC
10. Publication Provides a Wake-Up Call For Clinicians Treating Narcolepsy
11. American Media, Inc. Provides Lenders With Updated Information
Post Your Comments:
(Date:11/21/2008)...ead to new therapies for preterm labor , ... say they,ve found the switch that activates the u...a finding that may lead to therapies for preterm l...ds the protein IP on the surface of these uterine ...ing pregnancy. , But researchers from Dartmout...
(Date:11/21/2008)...a., Nov. 21 During a m...Edward G. Rendell today remembered Lieutenant Gove...an important partner in public service, and a tire... , "As the first woman elected lieutenant gove...vant," said Governor Rendell. "Her family and her ...
(Date:11/21/2008)... Banzel proved effective against Lennox-Gastaut sy...ws) -- A new drug called Banzel (rufinamide) has b...vere form of epilepsy called Lennox-Gastaut syndro...d Friday. , The approval was based on results o...ts ages 4 to 30. Compared to patients who took a p...
(Date:11/21/2008)...lders Intend To Vigorously Protect Investment And ...ov. 21 Dr. Stephen Joff...ndment to their Schedule 13D with the U.S. Securit... filed a 13D disclosing ownership of 11.4% of LCA-...LasikPlus fixed-site laser vision correction cente...
Breaking Medicine News(10 mins):Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7[0] Scientists ID Uterine Muscle Switch for Contractions[0] Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute[0] FDA Approves New Drug for Severe Epilepsy[0] Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company
...loped a micro capsule coated with silicon, which c...ection.This microchip works by absorbing nutrient...ucing cells.Some diabetics have to inject insulin ...r blood sugar levels. The device is being develope...
...e of disability in the United States, affects more...ances in treatment options and educational efforts...d and poorly treated in the US. In fact, a recent ...ns with serious mental illness fail to receive ade...
...hat children have the greatest increase in bone mi...Children who do not take enough exercise are in da...ys the study. Many fail to strengthen up their ske...efore puberty, which is critical to building healt...
...evel electromagnetic fields (EMF) at home could do...national study has found. //The three-year review ...n Non-Ionizing Radiation Protection (ICNIRP) by si...nstitutions around the world. Leukemia, which deve...
Other Medicine News:(Date:11/20/2008)...all/ -- PAREXEL International Corporation (Nasdaq:...ices provider, today announced that it has opened ...ulting and clinical research capabilities. With th...ations throughout five important biopharmaceutical...ntina, Brazil, Chile, and Mexico. This expansion f...
(Date:11/19/2008)...Newswire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) an...diary of,Takeda Pharmaceutical Company Limited (T... Phase 3 MONET1 trial evaluating motesanib (AMG 70... for the first-line treatment of,advanced non-sma...uspended,following a planned safety data review o...
(Date:11/19/2008)...swire/ -- Biotech scientists increasingly are appl...to better understand the effects of novel drug can...netic Engineering & Biotechnology News ( GEN ...a new compound,s mechanism of action and eventuall...cording to the November 15 issue of GEN . ( http:...
(Date:11/18/2008)...rstCall/ -- NeuroDiscovery Ltd (ASX:,NDL), a spec...opment Company,and Sosei Group Corporation ("Sos...ional biopharmaceutical company, today announce th...re-clinical efficacy data for NSL-043/SD118.,This...europathic pain and has,successfully completed Ph...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 9173 1AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 9173 2AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 9173 3AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 9173 4AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 9173 5AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 9173 6AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 9173 7AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 9173 8AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 9173 9China Information Security Technology Inc Issues Guidance 26 Discuss Outlook for 2009 29750 1China Information Security Technology Inc Issues Guidance 26 Discuss Outlook for 2009 29750 2China Information Security Technology Inc Issues Guidance 26 Discuss Outlook for 2009 29750 3China Information Security Technology Inc Issues Guidance 26 Discuss Outlook for 2009 29750 4China Information Security Technology Inc Issues Guidance 26 Discuss Outlook for 2009 29750 5KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10 Q 29749 1KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10 Q 29749 2KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10 Q 29749 3KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10 Q 29749 4Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 29745 1Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 29745 2Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 29745 3Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 29745 4Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 29745 5Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 29745 6[0] PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru[0] Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer[0] GEN Reports on the Trend Toward Predictive Toxicogenomics[3] Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting
... 2007 /PRNewswire-FirstCall/ --,EntreMed, Inc. , a...therapeutics for the treatment of cancer and infla...eclinical results for its Aurora,kinase - angiogen...ed during oral and poster presentations by EntreMe...scovery Conference,being held May 31 - June 1, 200...
... International Conference on Avian,Influenza at Fr...Newswire-FirstCall/ -- Very low doses of,Novavax I...on,against a lethal challenge of live H5N1 viruses...day at the Second International,Conference on Avia...6 microgram doses of Novavax,s,virus-like particle...
Other Medicine Technology:EntreMed's Aurora Kinase Inhibitor Induces Tumor Regression in,Preclinical Models 2EntreMed's Aurora Kinase Inhibitor Induces Tumor Regression in,Preclinical Models 3Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 2Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 3Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 4Vannas Capsulotomy scissors angled forward
Gills-Vannas side angled capsulotomy flat handle scissors
Vannas angled capsulotomy flat handle scissors
No. 1. 30 mm conventional blades. Thin well-rounded tips.
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |